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Generation of mice with longer and better
preserved telomeres in the absence of genetic
manipulations
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Although telomere length is genetically determined, mouse embryonic stem (ES) cells with
telomeres of twice the normal size have been generated. Here, we use such ES cells
with ‘hyper-long’ telomeres, which also express green fluorescent protein (GFP), to generate
chimaeric mice containing cells with both hyper-long and normal telomeres. We show that
chimaeric mice contain GFP-positive cells in all mouse tissues, display normal tissue histology
and normal survival. Both hyper-long and normal telomeres shorten with age, but
GFP-positive cells retain longer telomeres as mice age. Chimaeric mice with hyper-long
telomeres also accumulate fewer cells with short telomeres and less DNA damage with age,
and express lower levels of p53. In highly renewing compartments, such as the blood, cells
with hyper-long telomeres are longitudinally maintained or enriched with age. We further
show that wound-healing rates in the skin are increased in chimaeric mice. Our work
demonstrates that mice with functional, longer and better preserved telomeres can be
generated without the need for genetic manipulations, such as TERT overexpression.
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elomeres are nucleoprotein structures localized at the
ends of chromosomes, which in vertebrates consist of
tandem repeats of the TTAGGG DNA sequence ending in
a 30overhang of the G-rich strand1,2. Telomeres protect
chromosome ends from degradation and DNA repair activities
and are essential for chromosome stability1,3,4. The shelterin
complex, composed of six proteins, binds telomeric repeats and is
involved in telomere protection and telomere length regulation1,5.
Telomere length decreases associated to cell division due to the
inability of the replication machinery to copy the very ends of
chromosomes6,7. Telomerase, a reverse transcriptase, can add de
novo repeats onto telomere ends8,9 and in this manner can
elongate or maintain telomeres in cells where it is active, such as
cancer cells and pluripotent stem cells10–13. In the adult
organism, telomerase activity is restricted to adult stem cell
compartments, which also show the longest telomeres; however,
this is not sufficient to prevent progressive telomere shortening
with ageing14–16. When telomeres become critically short, they
impair stem cell function17 and the regenerative capacity of
tissues12. At the molecular level, critically short telomeres
trigger a persistent DNA damage response that leads to
senescence or apoptosis18,19. There is mounting genetic
evidence supporting the notion that accumulation of critically
short telomeres leads to ageing and ageing-associated diseases
both in mice and humans20–25. In particular, telomerase-deficient
mice, which show accelerated telomere shortening owing to
telomerase deficiency, display organ dysfunction and accelerated
ageing24,26. A similar phenotype is observed in human diseases
with mutations in telomerase20,25,27. Telomere length is
genetically determined and varies inter species28–31. In addition,
the rate of telomere shortening and of accumulation of short
telomeres with age also varies between species. In particular,
while humans are born with an average telomere length of
B10–15 kb and they shorten at a rate of B70 bp per year, mice of
the Mus musculus C57BL6 mouse strain, are born with telomeres
B40–50 kb at birth, which shorten 100-times faster than in
humans, while the average telomere length in dogs varies between
11.4 and 27.9 kb and telomeres shorten 10-fold faster than in
humans16,31,32. Furthermore, the accumulation of short telomeres
is predictive of individual longevity both in birds and mice31,33.
We and others recently described that telomerase is activated
and telomeres elongated in the inner cell mass (ICM) of the
blastocyst in mice, where it resets the normal telomere length of
the unmodified species34,35. Interestingly, we also found that
in vitro expansion of mouse embryonic stem (ES) cells derived
from the ICM results in a further telomere lengthening until
doubling the normal telomere length of the ICM of the blastocyst,
a process that is associated to loss of heterochromatic marks35.
Importantly, this telomere elongation occurs in the absence of
modifications in the telomerase gene. These in vitro generated
telomeres are referred to as hyper-long telomeres35. Interestingly,
ES cells with hyper-long telomeres can be aggregated in morulae,
and can undergo development to the blastocyst stage maintaining
the hyper-long telomere phenotype35.
Here, we set to address the hypothesis of whether it would be
possible to modify the normal telomere length of the M. musculus
species by altering telomere length in ES cell in the absence of
genetic manipulations. Thus, we set to study whether ES cell with
hyper-long telomeres owing to in vitro passaging, were able to
give rise to chimaeric mice composed of cells with hyper-long
telomeres, and to study telomere length dynamics with ageing in
these mice.
Our results indicate that it is possible to generate mice bearing
cells with hyper-long telomeres and that these cells contribute
to the normal architecture and function of adult organs.
Interestingly, the accumulation of short telomeres with ageing
is reduced in cells bearing hyper-long telomeres, which in turn
results in lower accumulation of DNA damage in tissues with age.
In addition, cells with hyper-long telomeres are maintained with
ageing in highly proliferative compartments like blood, as well as
are able to heal skin wounds faster than cells bearing normal
length telomeres. These findings demonstrate that it is possible to
modify the telomere length of a mammalian species in the
absence of any genetic manipulation. This opens the possibility
of altering the rate of accumulation of short telomeres with ageing
in the absence of changes in telomerase expression, thus avoiding
its potentially undesired effects in facilitating cancer.
Results
Few passages required for ES cells with hyper-long telomeres.
We showed previously that ES cells lengthen their telomeres upon
in vitro expansion35. Thus, here we first addressed whether there
was a limit to telomere lengthening during expansion. To this
end, we subjected ES cells to over 60 passages in vitro and
analysed telomere length by quantitative fluorescence in situ
hybridization (Q-FISH) on metaphase spreads at different
passages. Mean telomere length was increased until passage 24
and then, was maintained until passage 60 (Fig. 1a and
Supplementary Fig. 1a), suggesting that a few passages are
sufficient to reach maximum telomere length in ES cells. This
finding was further confirmed by telomere Q-FISH and
telomapping techniques (Supplementary Fig. 1b,c). To discard
that differences in telomere length were caused by changes in
probe accessibility, or ploidy, we performed Q-FISH with a
centromeric major satellite probe and found no significant
differences in centromeric fluorescence at different passages
(Methods, Supplementary Fig. 2). To study whether other
changes might occur during in vitro expansion of ES cells, we
subjected four independent clones of ES cells at passage 6 and
passage 16 to RNA-deep sequencing and found only five genes
(out of 19,555 genes analysed) significantly differentially
expressed for a false discovery rate (FDR) below 0.05 analysed
using DESeq (Methods). These genes were Sox18 (upregulated
20-fold compared with ES cells at passage 6) and Sox17, Zbtb48,
Chst15 and Jph4 (downregulated less than twofold compared with
ES cells at passage 6) (Supplementary Table 1). Thus, RNA-seq
analysis showed very few changes in gene expression between ES
cells at passages 4 and 16. Importantly, we did not observe
alterations in mRNA expression of telomerase genes, nor in
components of shelterin, or in other genes associated to telomere
biology. We confirmed similar telomeric repeat amplification
protocol (TRAP) telomerase activity in passage 4 and passage 16
ES cells (Supplementary Fig. 3). Finally, none of the genes with
altered expression levels have been implicated in longevity36.
Proper telomere function requires binding of the shelterin
complex to telomeric repeats1,5. The shelterin protein TRF1
(telomere repeat binding factor 1) is involved in telomere capping
and telomere length regulation37–40. Interestingly, TRF1 is highly
expressed in ES cells as well as in induced pluripotent stem (iPS)
cells35,41 and this enrichment is also maintained in adult stem cell
compartments compared with more differentiated compartments
in the context of the organism41. Thus, we next asked
whether in vitro expansion of ES cells affected TRF1 levels.
To this end, we quantified TRF1 levels at a single-cell level by
immunofluorescence (IF) with anti-TRF1 antibodies using
confocal microscopy (Fig. 1b,c). We found higher TRF1 levels
in the ICM of the blastocyst compared with the trophectoderm or
to mouse embryonic fibroblasts (Fig. 1b,c and Supplementary
Fig. 4a,b). Interestingly, we found that early passage ES cells
(up to passage 24) retained similarly high TRF1 levels to those
present in the ICM but TRF1 levels decreased at higher passages,
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which may reflect a change in ES cell properties at later passages.
These results indicate that maximal telomere length is achieved
and high TRF1 levels are maintained after moderate in vitro
passaging of ES cells (up to passage 24).
ES cells with hyper-long telomeres do not show increased DNA
damage. We next asked whether continuous telomere
lengthening associated to in vitro ES cell expansion would cause
DNA damage, particularly at regions difficult to replicate such as
telomeres. gH2AX is a marker of double-strand breaks and
dysfunctional telomeres, the latter also known as telomere
damage-induced foci or telomere-induced foci (TIFs)42,43.
To asses DNA damage specifically at telomeric chromatin, we
performed double IF with anti-gH2AX and TRF1 antibodies to
quantify TIFs (Fig. 1d–f). We found very few ES cells with DNA
damage (43 gH2AX foci per cell) up to passage 24, but this
percentage significantly increased at later passages with more
than 40% of the cells showing DNA damage (Fig. 1d). In the case
of telomere-specific damage, we also observed low numbers of
TIF-positive cells until passage 24, and this was significantly
increased at later passages (Fig. 1e,f). We found similar results
when we analysed telomere damage by telomere FISH combined
with IF using anti 53BP1 antibody (Supplementary Fig. 4c,d).
To study the specific type of DNA damage present at later
passages in cells with hyper-long telomeres, we arrested cells
with colcemid and performed telomere Q-FISH on metaphase
spreads. We found that the only telomere aberration increased
with ES cell passaging was the presence of multitelomeric signals
(MTS) (Fig. 1g,h), a type of aberration previously associated
to increased telomere fragility as the result of replication stress
at telomeres13,44. Interestingly, TRF1, which is also decreased at
later passages (Fig. 1b), has been previously shown to protect
from telomere fragility38,44.
Taken together our results demonstrate that hyper-long
telomeres after moderate ES cell passaging (up to 24 passages)
are well capped and do not show increased DNA damage.
Hyper-long telomeres contribute to healthy chimaeric mice.
We next addressed the capability of ES cells bearing hyper-long
telomeres to contribute to chimaera formation in vivo and to
retain hyper-long telomeres in the adult organism (Fig. 2a–f). To
this end, we aggregated GFP-positive ES cells with hyper-long
telomeres (passage 16) with eight-cell morulae, and derived from
them chimaeric mice (see Fig. 3a; note longer telomeres in
GFP-positive ICM cells compared with the GFP-negative ICM of
the unmodified species). Gross phenotypic analysis of the
resulting chimaeric mice showed that they were normal com-
pared with the unmodified species. To track cells derived from
GFP-positive ES cells with hyper-long telomeres, we performed
immunohistochemistry of different tissues with an anti-GFP
antibody. In particular, we focused our analyses in the intestine
and the skin as an example of two highly proliferative tissues, as
well as in the brain, as an example of a low proliferative tissue.
Tissues were analysed at four time points during the mouse
lifespan: 0; 1; 6; and 12 months of life. We observed the presence
of both GFP-positive and -negative cells in all tissues analysed
(Fig. 2a,b). The percentage of GFP-positive cells was B20–50 per
cent in all tissues studied, and this was maintained when
chimaeric mice were analysed at different time points indicating
that cells bearing long telomeres are functional and maintained
with ageing (Fig. 2a,b). Importantly, these chimaeric tissues
showed a normal histology and we did not observe any
pathological finding (Fig. 2a and Supplementary Fig. 5a). To
study dynamically the fate of cells with hyper-long telomeres
in vivo, we performed a longitudinal analysis of the percentage of
cells expressing GFP in peripheral blood samples from chimaeric
mice bearing either normal or hyper-long telomeres (Fig. 2d)
from 4 until 8 months of age. We found that GFP-positive cells
with hyper-long telomeres are maintained, or even increased in
some cases, over time with respect to the starting point (Fig. 2d).
As control, while GFP-positive cells containing normal telomere
length were also maintained with time (Supplementary Fig. 5b).
We further confirmed telomere length in GFP-positive or -
negative cells by Q-FISH in blood samples from these chimaeric
mice (Supplementary Fig. 6a). Note that in chimaeric mice
bearing GFP-positive cells with normal telomere length both the
GFP-positive or -negative cells display similar telomere intensities
(upper graph and pictures), while in chimaeric mice bearing
GFP-positive cells with hyper-long telomeres, GFP-positive cells
display brighter telomeres than the GFP-negative cells (lower
graph and pictures; Supplementary Fig. 6a,b).
Because the chimaeric mice contained two different genetic
backgrounds (Fig. 2e), 129S1 cells (with hyper-long telomeres)
and CD1 cells (with normal length telomeres) from receptor
morulae, we compared telomere length in the chimaeric mice
with age-matched mice of the 129S1 and CD1 backgrounds in
newborns and 6-months-old chimaeric mice. As shown in Fig. 2f
and Supplementary Figs 6c and 7, GFP-positive cells, bearing
hyper-long telomeres had a higher mean telomere length than
cells of both the 129S1 and CD1 backgrounds with normal length
telomeres. Indeed, the mean telomere length was similar in the
chimaera eGFP-negative cells and in cells from non-chimaeric
mice from either background (Fig. 2f).
These results demonstrate the contribution of GFP-positive ES
cells with hyper-long telomeres to the formation of healthy tissues
and mice which contain GFP-positive cells with longer telomeres
than those of the unmodified species (GFP-negative cells). These
findings suggest that cells with hyper-long telomeres are main-
tained during both embryonic and adult mouse development.
Both long and normal length telomeres shorten with age. Next,
we sought to investigate the length dynamics of hyper-long
telomeres in the context of the organism with increasing age. To
this end, we performed Q-FISH using a telomere probe to mea-
sure telomere length combined with IF using anti-GFP antibody
to track the cells derived from ES cell with hyper-long telomeres
in sections from the intestine, skin and brain, from chimaeric
mice at 0, 1, 6 and 12 months of age (Methods). We confirmed
longer telomeres in the GFP-positive ES cells used for morulae
aggregation and in the derived GFP-positive ICM cells compared
with the GFP-negative ICM cells within the same blastocyst
(Fig. 3a,b and Supplementary Figs 8 and 9)35. After birth, we
observed telomere shortening with age in all mouse tissues
analysed, including the brain, in agreement with previous findings
(Fig. 3a and Supplementary Figs 8–10)16. At all the different ages
studied, we observed that the mean telomere length of
GFP-positive cells (derived from ES cells with hyper-long
telomeres) was higher than the mean telomere length of the
GFP-negative cells (derived from ES cells of the unmodified
species with normal length telomeres) in all tissues analysed
(Fig. 3a and Supplementary Figs 8 and 9), in spite of a slightly
increased rate of telomere shortening in the GFP-positive cells
(Fig. 3c), probably due to the starting differences in telomere
length in these cells. Note that cells with hyper-long telomeres
were never found or were very rare in the GFP-negative tissue
compared with the GFP-positive cells (Fig. 3a and Supplementary
Figs 7–9). Interestingly, we noticed that telomere shortening with
age was not uniform over time, with the highest rate of telomere
shortening per month occurring during the first month of life in
both the GFP-positive and -negative cells (Fig. 3c), which has also
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been observed in human blood45. This high rate of telomere
shortening also affected to the brain. This fast telomere
shortening soon after birth may reflect on the higher
proliferation rates in newborn mice to reach the size of adults.
In summary, these findings indicate that telomere shortening
occurs associated with ageing in the context of mouse tissues in
both cells derived from ICM of the recipient blastocyst








































































































































































TRF1 int. ± s.e.m. (a.u.):
0.3 ± 0.00145 
Num. of cells/clones: 407/2
TRF1 int. < 0.2 a.u.:6.52%
TRF1 int. > 0.5 a.u.:0.54%
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Mean length ± s.e.m. (a.u.):
8,109 ± 334 
Num. of tel./clones: 1,493/2
Telomeres < 5 a.u.: 13.24%
Telomeres > 13 a.u.: 5.43%
ES P24 
Mean length ± s.e.m. (a.u.):
17,058 ± 355.5
Num. of tel./clones: 1,462/2
Telomeres < 5 a.u.: 3.05%
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with hyper-long telomeres (GFP-positive), and that this is
exacerbated during the first month of life. Importantly, adult
cells derived from GFP-positive ES cells with hyper-long
telomeres showed longer telomeres at any time point in all
tissues analysed indicating that we achieved generation of adult
tissues bearing longer telomeres than those of the unmodified
species without any genetic manipulation and in particular
without transgenic germ line telomerase overexpression.
To further confirm these results, we studied chimaeric mice
showing a 100% of chimaerism. In particular, we determined
telomere length, shelterin levels, as well as telomerase levels in
blood samples at 20 and 40 weeks after birth. We confirmed
longer telomeres in the 100% GFP-positive chimaeric mice with
hyper-long telomeres at both time points compared with 100%
GFP-positive cells chimaeric mice with normal telomere length,
as well as compared with chimaeric mice with normal telomeres
and age-matched control mice (Supplementary Fig. 11a,c).
In addition, 100% chimaeric mice with hyper-long telomeres
showed less percentage of short telomeres compared with 100%
chimaeric mice with normal telomere length (Supplementary
Fig. 11a–c). We then analysed the levels of different shelterin
proteins in 100% chimaeric mice with normal or hyper-long
telomeres. By IF, we found similar levels of TRF1 or RAP1
shelterins in blood samples from either 100% chimaeric mice with
normal or hyper-long telomeres (Supplementary Fig. 11d–f).
By quantitative PCR, we also confirmed similar mRNA levels of
shelterin and telomerase, both in blood and skin samples from
100% chimaeric mice with normal or hyper-long telomeres or
controls (Supplementary Fig. 12). Finally, we demonstrate similar
telomerase TRAP activity in spleen from chimaeric mice with
normal length and hyper-long telomeres as well as in the control
mice (Supplementary Fig. 13).
These results suggest that mice with hyper-long telomeres do
not have globally an altered expression of shelterin or telomerase
gene compared with control mice.
Longer telomeres in adult stem and differentiated cells. Stem
cell compartments are enriched in cells with the longest telomeres
compared with the more differentiated compartments within the
same tissue both in mice and humans16,46. Furthermore, long
telomeres are advantageous for stem cell function in vivo17, as
critical telomere shortening in stem cells impairs their ability to
mobilize and regenerate tissues17 and short telomeres impair self
renewal and repopulation capacity in blood and intestine47,48.
Thus, we set to address whether stem cells derived from
GFP-positive ES cells with hyper-long telomeres retained longer
telomeres in the adult organism. In particular, we compared
telomere length in GFP-positive and negative cells located at
known stem cells compartments in both the skin and small
intestine. Briefly, we combined IF with anti-GFP antibody with
telomere Q-FISH on tissue sections to generate maps of telomere
length at a single-cell level within tissues (immuno-telomapping;
Methods). In the case of the intestine and skin from 6-month-old
chimaeric mice (Fig. 4), GFP-positive cells located at known stem
cell compartments (the intestinal crypts in the case of the small
intestine and hair bulge in the case of the skin) had longer
telomeres than the GFP-negative counterparts at the same
compartments (Fig. 4a–d). In the case of the differentiated
compartments (villi and basal layer), we also observed longer
telomeres in the GFP-positive cells compared with the
GFP-negative neighbouring cells (Fig. 4a–d).
Together, these results indicate that aggregation of ES cell
with hyper-long telomeres results in both adult stem cell
compartments and differentiated compartments containing
cells with longer telomeres compared with the corresponding
adult compartments in the unmodified species. This finding is in
agreement with the fact that the percentage of GFP-positive cells
in the tissues studied is similar in chimaeric mice of different ages.
Lower accumulation of short telomeres with aging. Next, we
addressed whether the accumulation of cells with short telomeres
with ageing was also lower in GFP-positive cells. In M. musculus,
the 10% percentile in the reference population (in this case, the
GFP-negative newborns, whose telomere length is similar to the
129S1 unmodified species in age-matched animals) is used to
quantify short telomeres. Percentile 10% corresponded to a
telomere length of approximately o15 kb (ref. 31). The
percentage of cells with short telomeres was zero in the case of
the ICM of the blastocyst for both genetic backgrounds (Fig. 5).
Strikingly, the percentage of cells with short telomeres was lower
for the GFP-positive cells at the different ages and tissues studied
(Fig. 5a). Interestingly, tissues with a higher rate of proliferation
accumulated more cells with short telomeres in both positive and
negative GFP cells at the 12 months time point (Fig. 5a). In both
positive and negative GFP cells, the biggest increase in the
percentage of cells with short telomeres occurred during the first
month of life (Fig. 5b), in agreement with a faster rate of telomere
shortening early in life, until the adult organism is formed. Of
note, after the first month of life, and for the rest of the time
points analysed, the biggest accumulation of cells with short
telomeres continued to occur in the GFP-negative cells.
Our results suggest that adult cells derived from ES cell with
hyper-long telomeres preserve longer telomeres and accumulate
lower numbers of short telomeres with age.
Mice with longer telomeres show less DNA damage and tumours.
First, as an indication of proper telomere capping, we examined
TRF1 levels in both GFP-positive and -negative cells. TRF1 is
an essential shelterin component that plays a role in telomere
protection by preventing telomere fragility and fusions, which in
turn are associated to premature tissue ageing and increased
cancer susceptibility5,13,44,49. To this end, we analysed TRF1
Figure 1 | Analysis of ES cells bearing hyper-long telomeres. (a) Mean telomere length analysed on metaphase spreads in primary MEF (passage 2) and
ES cells at the indicated passages. The ‘M’ in the graph indicates the number of metaphases studied. Underneath, the two graphs show the histograms
corresponding to telomere signals in the primary MEFs and ES cells at passage 24. (b) Mean TRF1 intensity in primary MEFs (passage 2), blastocysts and
ES cells at the indicated passages. Underneath, the graphs show the histograms for TRF1 intensity in MEFs and ES cells at passage 24. (c) Representative
micrographs of TRF1 stain in selected samples described in b. Scale bar, 10 mm. (d) Per cent of cells with DNA damage measured by IF with anti gH2AX
antibody in primary MEFs (passage 2) and ES cells at the indicated passages. We show a representative graph of three independent experiments.
(e) Per cent of cells with more than two TIFs, analysed by IF with anti gH2AX and TRF1 antibodies in primary MEFs (passage 2) and ES cells at the indicated
passages. We show a representative graph of three independent experiments. (f) Representative micrographs of control or damaged cells. Cells were
subjected to IF with anti gH2AX and TRF1 antibodies. Co-localization of gH2AX and TRF1 is indicated with yellow arrows. Scale bar, 10mm. (g) Mean
number of MTS in metaphases from ES cells at the indicated passages, analysed by telomere FISH. Representative graph of two independent experiments.
(h) Representative images of metaphases at passages 5 and 50. A representative telomere shape is highlighted in each micrograph. Scale bar, 5mm.
n¼ number of independent primary MEFs or clones of ES cells. The s.e.m. was represented in error bars. Student t-test with the Bonferroni correction was
used to calculate the P values. MEF, mouse embryonic fibroblasts.
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129S1 background coming from ES cells
at passage 4 expressing GFP (      ),
microinjected in morulae of the C57BL6
background (      )
129S1 background coming from ES cells
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background (       )
Chimaeric mice with hyper-long telomeres






































Figure 2 | Tissues bearing cells with hyper-long telomeres are healthy. (a) Micrographs show histology of intestine, skin and brain from chimaeric mice
bearing cells with normal telomere length and other cells with hyper-long telomeres (GFP-positive). Note that tissues containing GFP-positive cells are
healthy. Scale bar, 50mm. (b) The graphs show the percentage of GFP-positive cells found in intestine, brain and skin of chimaeric mice bearing hyper-long
telomeres, over the period of time indicated. (c) The scheme shows how chimaeric mice were generated. (d) Per cent of GFP-positive cells in blood from
chimaeric mice bearing hyper-long telomeres during the period of time is indicated. (e) Scheme shows that the chimaeric mice analysed were constituted
by two different backgrounds, 129S1 with hyper-long telomeres and CD1 cells with normal length telomeres. (f) Graphs show mean telomere length in
intestine, skin and brain in newborns and 6 months chimaeric mice compared with aged-matched animals from the 129S1 and CD1 backgrounds.
Representative graph of two independent experiments. The s.e.m. was represented in error bars. Student t-test with the Bonferroni correction was used to
calculate the P values. E&H, eosin and haematoxylin.
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Figure 3 | Both hyper-long and normal length telomeres shorten with age in vivo. (a) The scheme shows how the chimaeric mice were generated.
Underneath, The graphs show mean telomere length in ES cells used for microinjection, The ICM of the blastocyst, intestine, skin and brain from chimaeric
mice bearing hyper-long (GFP-positive) and normal length (GFP-negative) telomeres, at the indicated time points. Samples were subjected to IF with
anti-GFP antibody combined with telomere FISH. Telomere length was analysed by telomapping. Representative graph of two independent experiments.
(b) Representative images showing GFP-positive cells (green), GFP-negative cells and telomere FISH in blastocyst and in 1-month-old skin. Scale bar,
10mm. (c) Graphs present the rate of mean telomere length shortening per month in intestine, skin and brain for the indicated periods. n¼ number of
blastocyst, or independent clones of ES cell (passage 16) or independent chimaeric mice. Representative graph of two independent experiments. The s.e.m.
was represented in error bars. Student t-test with the Bonferroni correction was used to calculate the P values.
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Figure 4 | Hyper-long telomeres remain long in stem cell niches and differentiated compartments despite ageing. (a) Representative image of a 6
months chimaeric intestine after IF with anti-GFP antibody combined with telomere FISH (left). The map shows telomere intensity of each cell, analysed by
telomapping. The colour-intensity code is specified over the image (right). (b) Representative image of 6 months chimaeric skin after IF with anti-GFP
antibody combined with telomere FISH (left). The map shows telomere intensity for each cell, analysed by telomapping. The colour-intensity code is
specified over the image (right). Below, mean telomere-length quantification of the cells contained in the stem cell niches (crypt or hair bulge) and
differentiated compartments (villi and basal layer), differentiating the GFP-positive versus GFP-negative patches. Note that longer telomeres coincide with
the GFP-positive patches. Representative images of five independent analysis. n¼ number of chimaeric mice. (c) Magnification of the square area in picture
a separating the telomere FISH and the GFP signals. (d) Magnification of the square area in b separating the telomere FISH and the GFP signals. Bar, 20mm.
The s.e.m. was represented in error bars. Student t-test with the Bonferroni correction was used to calculate the P values.
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abundance at telomeres in both ES cells used for aggregation
experiments as well as in 6- and 12-moths-old chimaeric mice. A
tendency to find the mean TRF1 intensity higher in the GFP-
positive cells than in the GFP-negative was observed in all the
tissues analysed (Fig. 6a and Supplementary Fig. 14), reflecting on
adequate telomere protection.
Next, we studied accumulation of DNA damage. Long
telomeres could be a target of DNA damage owing to more
difficulties to replicate repetitive DNA, although DNA damage
can occur independently of telomere length due to genotoxic
stress50,51. We determined DNA damage by % of cells showing
42 g-H2AX foci in tissues at 6- and 12-months-old animals
(Fig. 6b,c and Supplementary Fig. 15a). We observed a moderate
number of cells showing DNA damage in all the tissues analysed
and this increased with ageing, but there was a tendency to
accumulate more of these cells in the GFP-negative cells at both
time points, in agreement with shorter telomeres in these cells.
Although in this assay we cannot distinguish damage at telomeres
from other regions, these findings are in line with the notion that
longer telomeres are more efficiently protected from damage by
maintaining a functional telomere capping structure41,46,49.
In agreement with the lower DNA damage, we also detected
increased numbers of cells positive for p53 staining in the
GFP-negative population compared with the GFP-positive cells
both in intestine and skin (Fig. 6d and Supplementary Fig. 15b).
These results suggest that hyper-long telomeres are well capped in
the context of the organism as indicated by high levels of the
TRF1 protein, which in turn ensures a lower accumulation of
DNA damage and of p53 in tissues with ageing.
Importantly, we found that hyper-long telomeres did not result
in detectable long-term deleterious effects for mice, as indicated
by a similar survival of the chimaeric mice bearing cells with
hyper-long telomeres compared with chimaeric mice with normal
telomere length (see Fig. 6e). In line with this, we did not find
increased incidence of spontaneous tumours in the chimaeric
mice with hyper-long telomeres, indeed, none of the chimaeric
mice bearing hyper-long telomeres developed any spontaneous
tumours in the curse of the survival follow-up (Fig. 6f). To
further study whether hyper-long telomeres could be influ-
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Figure 5 | The amount of cells containing short telomeres is reduced in chimaeric mice containing hyper-long telomeres. (a) The graphs show the per
cent of cells with short telomeres in the ICM of the blastocyst, intestine, skin and brain at the indicated time points. Samples were subjected to IF with
anti-GFP antibody combined with FISH and analysed by telomapping. (b) Graphs show the increase in the per cent of cells with short telomeres per month
in intestine, skin and brain at the indicated time points. Samples came from chimaeric mice and were analysed as described in a. n¼ number of blastocysts
or chimaeric mice. Representative graphs of two independent experiments. The s.e.m. was represented in error bars. Student t-test with the Bonferroni
correction was used to calculate the P values.
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(DMBA) -phorbol 12-myristate 13-acetate (TPA) chemical carci-
nogenesis protocol on the skin of chimaeric mice with normal or
hyper-long telomeres, as well as age-matched controls (Methods).
DMBA was applied once on mouse skin, followed by TPA
treatment during 15 weeks. The evolution of papillomas was
further observed during at least 20 weeks after DMBA treatment.
After 20 weeks following DMBA treatment, only 129S1 control
mice showed papillomas, whereas C57BL6 control mice and
chimaeric mice with normal and hyper-long telomeres did not
show papillomas (Fig. 6g and Supplementary Fig. 16). Note
that the C57Bl6 background is very resistant to papilloma
formation52–54. In addition, at 10 weeks after DMBA treatment,
we observed the presence of preneoplastic lesions such as
parakeratotic hyperkeratosis, produced by external addition of
TPA and not due to inflammation processes since neutrophils were
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mice and chimaeric mice with normal telomere length. Intere-
stingly, in chimaeric mice with hyper-long telomeres, the patches
of skin with hyper-long telomeres (GFP-positive cells) did not
show presence of hyperkeratosis while these lesions were readily
observed in the patches of skin with normal length telomeres
(GFP-negative cells) from the same mice (see Fig. 6h,i).
Cells with hyper-long telomeres show better skin wound healing.
Previous studies have shown that wild-type long telomeres have
advantageous effects over short telomeres in the context of the
telomerase-deficient mouse model, particularly in the ability of
skin stem cells to mobilize and maintain skin homeostasis17 and
liver regeneration48. Here, we wondered whether hyper-long
telomeres would be advantageous compared with normal length
telomeres in the context of the organism. To address this, we
generated two types of chimaeric mice: chimaeric mice with
normal length telomeres by microinjecting ES cells at passage 4
(telomere length being similar to telomere length of the inner
cells mass of the blastocyst35) in morulae and expressing GFP
(in order to follow these cells in chimaeric tissue), as well as
chimaeric mice with hyper-long telomeres by microinjecting ES
cells expressing GFP at passage 16 (with hyper-long telomeres)
(see scheme in Fig. 7a). In particular, ES cells with normal or
hyper-long telomeres were microinjected in recipient morulae of
the C57Bl6 background. Adult chimaeric mice bearing either
normal or hyper-long telomere between 6 and 12 months and
adult non-chimaeric mice of the 129S1 or C57Bl6 backgrounds
(used as age-matched controls) between 6 and 12 months were
anaesthetized to remove the back hair with depilatory cream.
After a period of 3 days, they were anaesthetized again to cause
superficial wounds of 4 mm diameter with a circular razor blade.
We quantified the surface of the 4 mm wound every day. The
area of the wound was reduced with days until its closure. In
chimaeric mice with normal telomere length wounds were
healed at the same rate than in control non-chimaeric mice
(Fig. 7b). In contrast, in chimaeric mice with hyper-long
telomeres, we found that rate of wound-healing was higher in
the GFP-positive cells with hyper-long telomeres compared with
the GFP-negative cells and the in the non-chimaeric age-
matched controls (Fig. 7b,c and Supplementary Fig. 17).
Telomere length was analysed in the skin extracted from
chimaeric mice with either normal or hyper-long telomeres as
well as in age-matched controls when wounds were caused,
confirming longer telomeres in the GFP-positive cells
derived from ES cells with hyper-long telomeres
(Supplementary Fig. 18). Histopathology analysis confirmed
that GFP-positive cells contributed to wound-healing in the
chimaeric mice with hyper-long telomeres (Supplementary
Fig. 19). Together, these results indicate that hyper-long
telomeres are advantageous for skin regeneration compared
with normal length telomeres.
Discussion
It has been previously shown that telomere length is a molecular
determinant of ageing and lifespan in mice22,55–58. On one hand,
short telomeres lead to accelerated ageing22,24,26,47 and longer
telomeres owing to telomerase overexpression can delay ageing
and increase lifespan in mice55,59. All these studies have been
carried out using genetic manipulations of the telomerase genes
either throughout generation of genetically modified mice or
through the use of gene therapy strategies26,55–59. Here, we set to
address the possibility of generating mice with longer telomeres
than normal in the absence of any genetic manipulation.
We previously showed that telomeres lengthen during in vitro
expansion of ES cells35. This telomere lengthening occurs
simultaneously to the loss of heterochromatic marks at
telomeres and in the absence of changes in the global DNA
methylation (SINE elements) or subtelomeric methylation or
telomerase activity35. This phenomenon is also recapitulated
when differentiated cells are reprogrammed to iPS cells and
expanded in vitro, again associated to changes at telomeric
heterochromatin13. Of note, in the absence of telomerase
differentiated cells can be reprogrammed to iPS cells, but
telomeres do not lengthen13. These observations suggested that
is possible to generate cells with hyper-long telomeres simply by
in vitro passaging and, thus, in the absence of manipulation of the
telomerase gene. However, it remained unknown whether cells
derived from ES cells with hyper-long telomeres are maintained
throughout embryonic and adult development in mice, and they
retain longer telomeres and lower ageing-associated DNA
damage in the adult organism. We first observed moderately
passaged ES cells (up to passage 24) showed maximum telomere
length and similarly high levels of the TRF1 protein to those
characteristic of pluripotent ES cell and iPS cells41,60 as well as of
cells of the in vitro cultured ICM35. Of note, excessive passaging
(that is, passage 60), resulted in decreased TRF1 levels and in
accumulation of telomere damage as indicated by increased
presence of TIFs and MTS, a telomere aberration associated with
telomere fragility and indicative of telomere replication
defects38,44. These aberrations could be associated to decreased
levels of TRF1 protein at late ES cell passages, as TRF1 protects
cells from both types of damage38,44. Of note, in spite of
decreased TRF1 protein levels at later passages, we did not
observe increased telomere fusions, suggesting that a minimum
threshold for telomere capping is safeguarded in ES cells.
Together, these observations indicate that only a limited
Figure 6 | Analysis of TRF1 and DNA damage in chimaeric tissues. (a) Mean TRF1 intensity in cells bearing normal (GFP-negative) or hyper-long
telomeres (GFP-positive) in ES cells used for the generation of chimaeric mice, and in brain, intestine and skin from the chimaeric mice at 6 and 12 months.
Tissues were subjected to IF with anti-GFP and anti-TRF1 antibodies. Representative graphs of two independent experiments. (b) Per cent of cells positive
for gH2AX in brain, intestine and skin tissue from chimaeric mice at 6 and 12 months. Tissues were subjected to IF with anti-GFP and anti-gH2AX
antibodies. Representative graphs of two independent experiments. (c) Representative images of brain tissues as described in b. Scale bar, 10mm. (d) The
graph shows the per cent of P53-positive cells in skin from 1-year-old chimaeric mice bearing hyper-long telomeres for both GFP-positive and -negative
cells. Underneath, a representative image of intestine stained for GFP and P53 and in 1-year-old chimaeric mice. The yellow arrowhead indicates GFP stain
and the red arrow indicates p53 stain. Scale bar, 50mm. (e) The graph shows the per cent survival of three different cohorts of mice, chimaeric mice with
normal telomere length, chimaeric mice bearing cells with hyper-long telomeres and control mice. (f) The graphs show the percentage of spontaneous
tumour incidence in the three cohorts of mice described in e. (g) Chemical carcinogenesis experiment. The graph shows the total number of papillomas in
chimaeric mice bearing hyper-long telomres, normal length telomeres or in age-matched mice of the 129S1 and C57Bl6 backgrounds. Representative graph
of two independent experiments. (h) The graph shows the percentage of area affected by hyperkeratosis in the mice described in g. Representative graph of
two independent experiments. (i) Representative micrograph of back skin of mice affected with hyperkeratosis. (j) E&H images on skin affected with
hyperkeratosis. The lesion was diagnosed parakeratotic hyperkeratosis, as no signs of inflammation were observed. n¼ number of independent clones of ES
cells or chimaeric or control mice. Scale bar, 50mm. The s.e.m. was represented in error bars. Student t-test with the Bonferroni correction was used to
calculate the P values, except for the graph of e, where a log rank test was used. E&H, eosin and haematoxylin.
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Figure 7 | Wound-healing in chimaeric mice with normal or hyper-long telomeres. (a) Scheme shows that the chimaeric mice analysed were constituted
by two different backgrounds, 129S1 and C57Bl6. While C57Bl6 background contains cells of normal telomere length, the 129S1 cells contains cells with
normal telomere length (from ES at passage 4) or cells bearing hyper-long telomeres (from ES cells at passage 16). (b) The graph shows the per cent of
skin healed in chimaeric mice bearing normal or hyper-long telomeres and age-matched controls at 7 days after the wound on skin was performed. Wounds
were made with a circular 4 mm razor blade and pictures were taken. Representative graph of two independent experiments. (c) Representative images of
chimaeric mice (two coloured skin) and age-matched controls before and at day 7 after wounds were made. Photagraphs were taken every two days and
wounds were measured using Image J software at day 0 (when wounds were performed) and at day 7. The s.e.m. was represented in error bars. Student
t-test with the Bonferroni correction was used to calculate the P values.
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number of passages are necessary to generate pluripotent stem
cells with hyper-long telomeres and high levels of TRF1, in the
absence of telomere damage and telomere aberrations.
Furthermore, a moderate number of passages ensure a very
similar genome-wide expression profile between ES cells at early
passages as indicated by very few gene expression changes by
RNA-seq. Importantly, we did not observe any changes in the
expression of telomerase, shelterin proteins, or any other genes
related to telomere biology.
The main challenge in this study was the successful generation
of chimaeric mice derived from ES cells with hyper-long
telomeres (GFP-positive to allow lineage tracking), which contain
GFP-positive cells (up to B50% of cells in different tissues
analysed) with longer telomeres than those of the unmodified
species, both at the stem cell and more differentiated
compartments. Here, we obtained chimaeric mice, which show
much longer telomeres than those of the unmodified species in
the absence of changes in expression of telomerase or telomere-
binding proteins. Importantly, chimaeric mice and tissues were
healthy and did not display any histopathological alterations.
Interestingly, GFP-positive cells with hyper-long telomeres
maintained longer telomeres and showed a lower abundance
of cells with short telomeres at different times points up to 1 year
of age. In addition, GFP-positive cells showed lower levels of
telomere fragility and fusions, as well as lower DNA damage with
ageing. These results are in line with previous findings describing
that transgenic overexpression of TERT in mice from a different
genetic background (C57BL6), which also resulted in longer
telomeres, also showed a lower accumulation of DNA damage
with ageing61. Similar results were obtained by TERT
overexpression achieved by using a gene therapy strategy55.
We next tested whether having hyper-long telomeres was
advantageous or disadvantageous for cells in highly proliferative
compartments such as the blood and the skin. Longitudinal
studies in which we dynamically followed cells with hyper-long
telomeres in blood with ageing, showed that these cells were
maintained or even amplified over time, suggesting that
hyper-long telomeres are not disadvantageous and may be
positively selected. Also in line with this notion, by using skin
wound-healing assays, we observed that skin cells with
hyper-long telomeres were able to repair more rapidly the skin
wounds compared with the skin of the unmodified species.
Whether long telomeres are protective from cancer or may
increase the risk of tumour formation is still debated61,62. In our
previous studies, we showed that TERT gene therapy using AAV9
non-integrative vectors was sufficient to delay many age-related
diseases, including cancer22,55–58. In this regard, neither
chimaeric mice with hyper-long telomeres nor control mice
developed any tumour during the period of analysis, suggesting
that both hyper-long and normal telomeres behave similarly with
respect to tumour formation. Importantly, in line with this, we
found that hyper-long telomeres did not result in any long-term
deleterious effects for the mice, as indicated by a similar or
slightly increased survival of the chimaeric mice bearing cells with
hyper-long telomeres compared with chimaeric mice with normal
telomere length. In addition, chimaeric mice with hyper-long
telomeres did not demonstrate a shortened latency period for
tumour formation and continued tumour-free at week 20 after
the start of the treatment, although the final tumour yield is still
to be concluded.
Together, these findings demonstrate that cells bearing
hyper-long telomeres render juvenile telomeres in vivo.
These results are proof of principle that it is possible to
generate adult tissues with longer telomeres than normal in
the absence of genetic modifications. Future studies warrant
generation of a new strain of mice with hyper-long telomeres,
which will be instrumental to further study the impact of
hyper-long telomeres in species longevity. Finally, our results
highlight the importance of using of ES cells or iPS cells with long
telomeres for regenerative medicine.
Methods
Cell culture conditions and blastocyst collection. Procedures for embryo
collection, chimaera generation and animal experimentation were approved by
CNIO-ISCIII Ethics Committee for Research and Animal Welfare (CbyBA). The
two clones of in vitro cultured ES cells were from mice with a C57BL6 genetic
background. Chimaeric mice were the result of microinjection or aggregation of
R1-eGFP ES cells (obtained from A. Nagy, The Lunenfeld-Tanenbaum Research
Institute) from mice with a 129S1 genetic background in recipient morulae of the
C57BL6 or CD1 genetic background, respectively. Primary mouse embryonic
fibroblasts were obtained from 13.5-day embryos of C57BL6 mice as described21.
ES cells were cultured in complete KSR medium composed of DMEM
(high glucose; Gibco) supplemented with serum replacement (KSR 15%, Gibco),
LIF (1,000 U ml 1, Millipore).
Cells analysed by telomapping were pelleted, embedded in gelatin (from porcine
skin type A; Sigma) to a final concentration of 5% and fixed with 10% buffered
formalin overnight. Blastocysts were extracted by flushing the oviduct with M2
medium (Sigma), embedded in gelatin and fixed. Tissues from chimaeric mice were
extracted and fixed with 10% buffered formalin overnight. Paraffin blocks of the
fixed samples and the immunohistochemistry with anti-GFP antibodies were made
by the Comparative Pathology Unit of CNIO. In particular, the Comparative
Pathology Unit at CNIO, made paraffin blocks from the different mouse tissues
and generated 4 mm sections, which were then deparaffinized and used for
immunohistochemistry with hematoxylin and eosin (Panreac and Sigma,
respectively) and with the anti-GFP antibody (Roche Diagnostics S.L.; cat. number
11814460001; 1 mg ml 1; dilution 1:100) according to standard procedures.
Chimaera generation. Chimaeric mice were generated at the CNIO Transgenic
Mice Unit either by microinjection of R1-eGFP ES cells into Hsd:ICR (C57Bl6
background) morulae or by aggregation of the same ES cells with morulae
(CD1 background). Embryos were harvested from superovulated donor females at
E2.5 days of gestation. For the microinjection experiments, B60 morulae at the
eight-cell stage were microinjected with 6-10 EGFP-expressing R1-eGFP ES cells by
laser-assisted perforation of the ‘zona pellucida’. After microinjection, embryos
were incubated overnight in a drop of KSOM medium in a CO2 incubator at 37 C
under oil. For aggregation experiments, around 60 morulae at the eight-cell stage
were aggregated with around 12 cells EGFP-expressing R1-eGFP ES cells by
removal of the ‘zona pellucida’ with Tyrodés solution (Sigma). Embryos were
analysed for telomere length and eGFP fluorescence when they reached the blas-
tocyst stage (2 days after microinjection).
Wound-healing experiments. For the wound-healing experiments, 6–12-month-
old mice (both male and female) were anaesthetized with isoflurane (IsoFlo, Esteve)
and the back hair was removed with depilatory cream. After 3 days, they were
anaesthetised and superficial wounds were performed with a 4 mm circular razor
blade. Wounds were allowed to air-dry and photographed (a caliber was placed by
the side of the mice for quantification) to follow wound-healing and measured
using Image J software at the indicated times (see Supplementary Fig. 17).
Longitudinal telomere length analysis in peripheral blood. An amount of 100ml
of blood was extracted from the facial vein of 4-month-old mice (both male and
female) every following month during the next four months. Erythrocytes were
lysed with Buffer EL Erythrocyte lysis buffer (Qiagen). The rest of peripheral blood
cells were washed with 1 PBS, fixed, embedded in gelatin 5% (from porcine skin
type A; Sigma) and paraffin blocks were made. Sections from paraffin blocks were
stained with anti-GFP antibody and the per cent of GFP-positive cells was scored
by the Histopathology Unit of CNIO using Mirax Scan to digitalize the slide and
Axio Vision software to quantify images.
Skin chemical carcinogenesis assay. Age-matched (8–12-month-old, males as
well as females) chimaeric mice bearing either hyper-long or normal length telo-
meres, as well as age-matched controls were anaesthesized (using isoflurane; Esteve)
to remove 1 cm2 back-skin hair by using depilatory cream (Billy). A single dose of
DMBA (7,12-dimethylbenz(a)anthracene] (Sigma) (100 nM; 5mgr dissolved in 200ml
of acetone) was applied on the back skin of the mice to promote mutations which
could initiate cancer as described63. After a week, 12.5mg of TPA (tetradecanoyl
phorbol acetate) (Sigma) dissolved in 200ml of acetone was added two times per week
during 15 weeks. The number of papillomas was determined by eye and the size was
measured using a caliber and registered for each mouse on a weekly basis63. The
evolution of papillomas was followed for at least 20 weeks after DMBA treatment.
Quantitative FISH. ES cells were blocked in metaphase with colcemid (Gibco) for
3 h, swollen in hypotonic buffer for 10 min at 37 C, and fixed as described in
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ref. 64. Metaphases were dropped on slides and Q-FISH performed as in ref. 65.
TFL-Telo software66 was used to quantify the fluorescence intensity of telomeres
from 5 to 10 metaphases for each data point. Embryos and tissues in paraffin
blocks were serially sectioned (2-mm-thick sections) and rehydrated before
applying Q-FISH. A telomere (Panagene) or centromere (Panagene) probe labelled
with CY3 (Panagene) was used as described in ref. 65.
Microscopy. Metaphase cells were acquired with a Leica DM 6000B Fluorescence
microscope, using an objective HCX-Pl-APO 100x-1.4-0.100 as described in35.
Sections from cells or tissues subjected to IF or Q-FISH were acquired in a confocal
high-resolution microscope Leica TCS-SP5 (AOBS) as described in ref. 35. Images
were acquired with the sequential mode of the microscope to avoid light bleeding
into other channels. The sequential mode does two separated acquisitions, first for
the GFP and secondly for the CY3 dyes (Supplementary Fig. 6b).
For co-localiztion studies, typically 10 Z-sections were acquired with excitation
mercury lamp of 405 and 561 and argon source of 488 wavelengths. The
detector gain for the 488 and 561 emission lights were set between 750 and 800.
Co-localization was analysed in every focal plane and considered positive when the
two stains green and red overlapped yielding a yellow stain.
Telomapping of blastocysts sections. Quantitative image analysis was performed
on confocal RGB images using the Definiens platform (version XD). The DAPI
image was used to define the nuclear area and the Cy3 image or Alexa-488 images
to quantify telomere or TRF1 fluorescence. Nuclear segmentation was calculated
using the Cellenger module of Definiens software. Cy3 (telomere or centromere) or
Alexa-488 (TRF1; 1:400 dilution; Life Technology A11008; lot 1408830;
2 mg ml 1) fluorescence intensity was measured as ‘average grey value’ (total grey
value per nuclei) units (arbitrary units of fluorescence). These ‘average telomere
fluorescence’ values represent the average Cy3 or Alexa-488 pixel intensity for the
total nuclear area, therefore ruling out that differences in nuclear size may
influence telomere length measurements. Telomere fluorescence values for each
sample are exported to Excel to generate frequency histograms. Definiens also
provides images where the nuclear mask is substituted by colours associated to CY3
intensities, generating tissue-specific maps of telomere length.
IF combined with FISH. Antigen retrieval of the paraffin sections were done by the
Comparative Pathology Unit of CNIO. Samples were permeabilized with 0.5%
Triton X-100 for 1.5 h at room temperature. Cells were blocked in PBS with 5%
BSA and incubated overnight at 4C with antibodies against GFP (1:500 dilution;
Roche Diagnostics S.L.; cat. number 11814460001; 1 mg ml 1; dilution 1:400),
TRF1 (Abcam, cat. number Ab10579; lot 598474; dilution 1:100), anti-gH2AX
(Millipore, cat. number 05-636; lot 2138016; 1 mg ml 1; dilution 1:400), anti
53BP1 (Millipore, cat. number MAB3804; lot 1999450; 10 mg ml 1; dilution
1:400), anti Rap1 antibody (Bethyl Laboratories, ING; A300-306-A; 1 mg ml 1;
dilution 1:400) and rabbit anti-TRF1 generated in the laboratory (1:400 dilution; lot
226) (ref. 67). Secondary antibodies (Alexa Fluor 488 rabbit 1:400 dilution; Life
Technology A11008; lot 1408830; 2 mg ml 1) were incubated at room temperature
for 45 minutes. Samples were fixed in 4% formaldehyde, dehydrated and incubated
with a telomere probe labelled with CY3 (Panagene) as described in ref. 65.
RNA sequencing. One microgram of total RNA per sample was used. Sample
RNA Integrity Numbers were 10 when assayed on an Agilent 2100 Bioanalyzer.
PolyAþ fraction was purified and randomly fragmented, converted to double
stranded cDNA and processed through subsequent enzymatic treatments of end-
repair, dA-tailing, and ligation to adapters as in Illumina’s ‘TruSeq Stranded
mRNA Sample Preparation Part # 15031047 Rev. D’ kit (this kit incorporates
dUTP during second strand cDNA synthesis, which implies that only the
cDNA strand generated during first strand synthesis is eventually sequenced).
Adapter-ligated library was completed by PCR with Illumina PE primers (eight
cycles). The resulting purified cDNA library was applied to an Illumina flow cell
for cluster generation and sequenced on an Illumina instrument (see below) by
following manufacturer’s protocols.
Fastq68 files with 50-nt single-end sequenced reads were quality-checked with
FastQC (S. Andrews, http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)
and aligned to the mouse genome (GRCm38/mm10) with TopHat-2.0.10 (ref. 69),
using Bowtie 1.0.0 (ref. 70) and Samtools 0.1.19 (ref. 71), allowing two mismatches
and five multihits. Raw counts for genes were obtained with HTSeq v0.5.3p9
(ref. 72), using the mouse genome annotation data set GRCm38/mm10 from the
UCSC Genome Browser73. Differential expression was obtained with DESeq2
(ref. 74). Differences were considered significant when FDR-adjusted P values were
lower than 0.05 FDR.
Quantitative real-time PCR (qPCR). Total RNA was extracted from blood
samples free of erythrocytes with TRIzol (Invitrogen). The RNA in ethanol was
further purified with the RNAeasy Mini kit (QIAGEN) for RNA elution, following
the manufacturer’s instructions.
Total RNA of 300 mg of tail skin Skin was preextracted with the kit RNaesy
Fibrous Tissue Mini Kit (QUIAGEN) and further purified with the RNAeasy Mini
kit (QIAGEN) following manufacturer’s instructions. Up to 1 mg of RNA was used
to synthesize complementary DNA with the iScript cDNA Synthesis Kit
(BIO-RAD) according to manufacturer’s instructions. The levels of gene
transcription were determined using the primers for shelterins or telomerase
(described below) using the Power SYBR Green PCR Master mix (Applied
Biosystems). The PCR was carried out in a Quantstudio 6 Flex Real Time system
(Applied Biosystems). Primers used are in Supplementary Table 2.
Telomerase activity TRAP assays. ES cells were trypsinized and washed in PBS,
spleen was washed in PBS after isolation, and then S-100 extracts were prepared as
described in ref. 21. Three protein concentrations were used for each sample
(5, 2.5 and 1mg) for the ES cells, and two protein concentrations were used for each
sample (5 and 1mg) of spleen. Extension and amplification reactions and
electrophoresis were performed as described in ref. 21. A negative control was
included by preincubating each splenn extract with RNase for 10 min at 30 C before
the extension reaction and internal control for PCR efficiency was also included.
Statistical analysis. All statistical analyses in this study were performed using the
GraphPad Prism software version 5. Mean values reflect the arithmetic mean.
Mean values and the s.e.m. were calculated according to the number of clones or
mice used. Student’s t-test with ‘two tails’ was used to obtain the P value. To avoid
errors due to the multiple comparison problem we have applied the Bonferroni
correction to all Student́s t-test analysis.
A log rank test was used to calculate statistical differences in survival of the
different mouse cohorts. The number of mice used for the different experiments is
indicated in the Figures.
Data availability. RNA-seq gene expression data have been deposited in GEO
under accession code GSE76837. The authors declare that all other data supporting
the findings of this study are available within the article and its Supplementary
Information file.
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